Results 261 to 270 of about 86,919 (334)

Evaluation of a point-of-care coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and activated clotting time in dogs

, 2001
Laura W. Tseng, Dez Hughes, Urs Giger
openalex   +1 more source

Post‐Viral Acquired Idiopathic Purpura Fulminans Caused by Anti‐Protein S Antibodies

Acta Paediatrica, Volume 114, Issue 10, Page 2511-2517, October 2025.
ABSTRACT Acquired Idiopathic purpura fulminans is a rare pathology caused by anti‐protein S antibodies. We have conducted a literature review focusing on the most recent developments in diagnosis and management. Diagnosis is based on the demonstration of typical necrotic purpura lesions on the legs. Treatment must be initiated without delay by infusion
Alexandre Theron, Christine Biron‐Andreani, Eric Jeziorski   +2 more
wiley   +1 more source

Measurement of a Newly Developed Thrombomodulin Addition Activated Partial Thromboplastin Time Assay in Patients with Deep Venous Thrombosis

, 2001
Etsuji Suehisa, Masayuki Toku, Tomio Kawasaki, Yuzuru Kanakura   +3 more
openalex   +1 more source

2025 ACVIM Forum Research Abstract Program

Journal of Veterinary Internal Medicine, Volume 39, Issue 6, November/December 2025.
wiley   +1 more source

Higher plasma dicarbonyl levels are associated with liver fibrosis in obese individuals

Diabetes, Obesity and Metabolism, Volume 27, Issue 10, Page 5878-5888, October 2025.
Abstract Introduction Methylglyoxal (MGO) is a very reactive compound that modifies proteins, forming advanced glycation end products (AGEs) and activating inflammatory pathways. Elevated MGO levels have been linked to various diseases, including type 2 diabetes and atherosclerosis. However, the role of MGO and other glycating agents in the progression
Oluwatomisono I. Akinrimisi, Mijra Koning, Jean L. J. M. Scheijen, Abraham S. Meijnikman, Daniko P. Sindhunata, Sjoerd Bruin, Arnold van de Laar, Rutger Franken, Yair Acherman, Victor E. A. Gerdes, Max Nieuwdorp, Casper G. Schalkwijk, Nordin M. J. Hanssen   +12 more
wiley   +1 more source

Effects of temperature on partial thromboplastin time in heparinized plasma in vitro

, 2001
Michael Felfernig, A. Blaicher, Stephan C. Kettner, D. Felfernig, S. Acimovic, Sibylle A. Kozek‐Langenecker   +5 more
openalex   +1 more source

Variability of Argatroban Effects on the Multiple APTT Reagents in High and Low Coagulation Activity Samples

International Journal of Laboratory Hematology, Volume 47, Issue 5, Page 923-930, October 2025.
ABSTRACT Introduction Argatroban is routinely monitored using activated partial thromboplastin time (APTT), with a recommended target range of 1.5–3.0 times. Although this range was established based on clinical trial data, including several APTT reagents, the differences in reactivity among APTT reagents remain unclear.
Osamu Kumano, Masahiro Ieko, Teruto Hashiguchi, Takashi Ito, Satoshi Yamazaki, Sumiyoshi Naito, Masako Yamazaki   +6 more
wiley   +1 more source

Placental Dysfunction Is Associated with Dysregulated Fibrinolytic System Activation. [PDF]

Int J Mol Sci
Yatsenko T, Us I, Korolova D, Zhuk S, Dziuba H, Nalbat A, Kharchenko S, Vari SG, Chernyshenko V.   +8 more
europepmc   +1 more source

Acquired Haemophilia A Associated With Suspected Chronic Neutrophilic Leukaemia Presenting As Fatal Retroperitoneal Haemorrhage in an Elderly Patient. [PDF]

Cureus
Mir FUI, Nizam UA, Baba AH, Arshad S, Maqbool S, Mir M.   +5 more
europepmc   +1 more source

The Detection of Changes in Heparin Activity in the Rabbit: A Comparison of Anti-Xa Activity, Thrombelastography®, Activated Partial Thromboplastin Time, and Activated Coagulation Time

, 2002
Vance G. Nielsen
openalex   +1 more source